Euphrates Vascular, Inc. — Form D
Euphrates Vascular, Inc. of St. Louis, MO, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-01. The offering totals $7.2M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-01
- Form: D
- Accession: 0001752992-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.2M
- Amount sold: $6.0M
- Remaining: $1.2M
- Minimum investment: $5K
- Investors: 25
- Date of first sale: 2020-07-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401265
Issuer
- Name: Euphrates Vascular, Inc.
- CIK: 0001752992
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 8460 Watson Road, St. Louis, MO, 63119
- Phone: 518-944-3367
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Sean Morris | Executive Officer | Wildwood, MO |
| Martin Omid Akhavan | Director | Maple Grove, MN |
| Martin Omid Akhavan | Executive Officer | Maple Grove, MN |
| Sean Morris | Director | Wildwood, MO |
| Thomas Hillman | Director | Saint Louis, MO |
| Troy Long | Executive Officer | Boca Raton, FL |
| Jeffrey Blair | Director | Boca Raton, FL |
| Cathy Omid Matthes | Executive Officer | St. Louis, MO |
| Eric Moessinger | Director | San Francisco, CA |
| Robert Mitchell | Director | Pearland, TX |
| Tim Blair | Executive Officer | 20 S. Sarah Street, MO |
Other filings by this issuer (2)
More